Method for extracting four-taxone compounds with high-efficiency abduction
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NORTHEAST FORESTRY UNIVERSITY
- Publication Date
- 2008-07-16
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for efficiently inducing and increasing the content of paclitaxel and its semi-synthetic precursors in the fresh branches and leaves of Taxus chinensis. Background technique
[0002] Paclitaxel (paclitaxel, figure 1 ) is a diterpenoid compound with a pentamethylpentadecene skeleton, which is a natural anticancer drug extracted from the bark of Pacific yew (Taxus brevifolia) for the first time (Wani et al., 1971). It binds to tubulin, promotes its polymerization, inhibits the mitosis of cancer cells, and prevents the proliferation of cancer cells (Kelling et al., 2003; She Kun et al., 2001). In 1992, it was officially approved by the US FDA as a new anticancer drug. Breast cancer and lung cancer have a better effect. Studies in recent years have shown that paclitaxel also has certain potential in the treatment of other diseases, such as malignant melanoma (Roshid et al., 1994), rheumatoid arthritis (Oliver et al., 199...